Transcripts iBio, Inc.

Equities

IBIO

US4510337086

Market Closed - Nyse Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
2.38 ^USD	+6.73%		+8.68%	+73.72%

May. 28	Chardan Research Starts iBio With Buy Rating, $5 Price Target	MT
May. 13	IBio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : IBio, Inc. - Special Call	Mar. 27
Transcript : IBio, Inc., Q4 2022 Earnings Call, Sep 27, 2022	22-09-27
Transcript : IBio, Inc., Q3 2022 Earnings Call, May 12, 2022	22-05-12
Transcript : iBio, Inc., Q2 2022 Earnings Call, Feb 14, 2022	22-02-14
Transcript : iBio, Inc. - Shareholder/Analyst Call	22-01-31
Transcript : iBio, Inc. Presents at Cantor Global Healthcare 2021 Conference, Sep-27-2021 10:00 AM	21-09-27
IBio, Inc. Provides Revenue Guidance for the First Half, Second Half and Full Year of Fiscal 2022	21-09-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer